Clinical Outcomes Study of the Nexel Total Elbow

Recruiting N/A Interventional Study
Elbow Joint Destruction Post-traumatic Lesions Ankylosed Joints Advanced Rheumatoid Arthritis Joint Instability or Loss of Motion Acute Comminuted Articular Fracture of Elbow Joint Surfaces Bone Loss Contributing to Elbow Instability Bilateral Ankylosis From Causes Other Than Active Sepsis Post-traumatic Arthritis Degenerative Arthritis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
134 (estimated)
Sponsor
Zimmer Biomet · Industry
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patient is 18 years of age or older. * Patient must have signed Institutional Review Board (IRB)/Ethics Committee (EC)-approved informed consent. * Patient is a candidate for primary or revision total elbow arthroplasty, based on symptoms including at least one of the followin…
Contacts

Richard Marek

574-453-7567

richard.marek@zimmerbiomet.com

CONTACT

Ryan Boylan

574-527-7934

ryan.boylan@zimmerbiomet.com

CONTACT